CytomX Therapeutics, Inc.
CTMX$3.18▼ 1.24% 24h
CytomX Therapeutics, Inc.CTMX$3.18
-$0.0177(-0.55%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$541.19M
P/E ratio
—
EPS (diluted)
$-1.16
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$76.20M
Net income
$-17.37M
Net margin
-22.8%
Gross margin
—
Dividends & financials
CytomX Therapeutics, Inc. (CTMX) reported revenue of $76.20M and net income of $-17.37M, or $-1.16 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.